1 |
Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs
Robert S. Kerbel
Cancer Res Treat.2007;39(4):150-159. Published online 2007 December 31
DOI: http://dx.doi.org/10.4143/crt.2007.39.4.150
|
|
2 |
The Advantage of UFT in the Patients with Stage IA & IB Lung Cancer after Complete Resection
Doo Yun Lee
J Korean Med Assoc.2003;46(1):21-28. Published online 2003 January 31
DOI: http://dx.doi.org/10.5124/jkma.2003.46.1.21
|
|